Adjunctive clindamycin therapy in invasive β-haemolytic streptococcal infections - Authors' reply

Lancet Infect Dis. 2021 Jun;21(6):762-763. doi: 10.1016/S1473-3099(21)00259-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Clindamycin* / therapeutic use
  • Cohort Studies
  • Hospitals
  • Humans
  • Retrospective Studies
  • Streptococcal Infections* / drug therapy
  • beta-Lactams

Substances

  • Anti-Bacterial Agents
  • beta-Lactams
  • Clindamycin